C. Gwaltney

发表

Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review.

S. Shiffman, A. Shields, C. Gwaltney, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers.

Qianyu Dang, Saul Shiffman, William G Shadel, 2006, Journal of consulting and clinical psychology.

Kortdurende motivationele alcoholinterventie op spoedeisende hulp, individueel of met steun van een belangrijke ander

C. Gwaltney, W. Cioffi, P. Monti, 2017 .

Cost-effectiveness of motivational intervention with significant others for patients with alcohol misuse.

C. Gwaltney, D. Shepard, P. Monti, 2016, Addiction.

Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment.

S. Shiffman, J. Paty, M. Balabanis, 2007, Drug and alcohol dependence.

“Bring Your Own Device” (BYOD): The Future of Field-Based Patient-Reported Outcome Data Collection in Clinical Trials?

C. Gwaltney, S. Coons, P. O’Donohoe, 2015, Therapeutic innovation & regulatory science.

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

Elizabeth Molsen, Chad J. Gwaltney, N. Leidy, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Natural history of nicotine withdrawal.

S. Shiffman, C. Patten, J. Paty, 2006, Addiction.

Individual versus significant-other-enhanced brief motivational intervention for alcohol in emergency care.

C. Gwaltney, W. Cioffi, P. Monti, 2014, Journal of consulting and clinical psychology.

Dynamic self-efficacy and outcome expectancies: prediction of smoking lapse and relapse.

Saul Shiffman, S. Shiffman, J. Paty, 2005, Journal of abnormal psychology.

Cue-provoked craving and nicotine replacement therapy in smoking cessation.

Andrew J Waters, Saul Shiffman, S. Shiffman, 2004, Journal of consulting and clinical psychology.

Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry Disease

A. Hamed, P. DasMahapatra, C. Gwaltney, 2021, Orphanet Journal of Rare Diseases.

Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.

N. Leidy, D. Patrick, L. Burke, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Predictive Value of Baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation.

J. Mundt, C. Gwaltney, J. Greist, 2014, Innovations in clinical neuroscience.

Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases

A. Hamed, C. Gwaltney, R. Pulikottil-Jacob, 2020, Orphanet Journal of Rare Diseases.

Interactive Voice Response and Text-based Self-report Versions of the Electronic Columbia-Suicide Severity Rating Scale Are Equivalent.

J. Mundt, J. Paty, C. Gwaltney, 2017, Innovations in clinical neuroscience.

A Systematic Method for Selecting Patient-Reported Outcome Measures in Diabetes Research

C. Gwaltney, M. Reaney, P. Black, 2014, Diabetes Spectrum.

Immediate antecedents of cigarette smoking: an analysis from ecological momentary assessment.

S. Shiffman, J. Paty, M. Balabanis, 2002, Journal of abnormal psychology.

Using daily drinking data to characterize the effects of a brief alcohol intervention in an emergency room.

C. Gwaltney, P. Monti, N. Barnett, 2011, Addictive behaviors.

Development of a patient‐reported outcomes symptom measure for patients with nontransfusion‐dependent thalassemia (NTDT‐PRO©)

C. Gwaltney, M. Cappellini, X. Hu, 2018, American journal of hematology.

Validation of a patient‐reported outcomes symptom measure for patients with nontransfusion‐dependent thalassemia (NTDT‐PRO©)

C. Gwaltney, M. Cappellini, V. Viprakasit, 2018, American journal of hematology.

Symptoms and Functional Limitations in the First Year Following a Myocardial Infarction: A Qualitative Study

C. Gwaltney, Mona Martin, P. Mollon, 2017, The Patient - Patient-Centered Outcomes Research.

Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19

J. Paty, C. Gwaltney, M. Reaney, 2022, The Patient - Patient-Centered Outcomes Research.

Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases

C. Gwaltney, Stephanie E. Bean, L. Kjems, 2022, Advances in Therapy.

Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis

C. Gwaltney, C. Ivanescu, L. Kjems, 2022, Advances in Therapy.

PDB59 Content Validity of a New Patient-Reported Outcome Instrument to Assess Hypoglycemia: The Hypoglycemia Perspectives Questionnaire

C. Gwaltney, M. Dibonaventura, S. Ong, 2012 .

Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19

J. Paty, C. Gwaltney, M. Reaney, 2022, The Patient - Patient-Centered Outcomes Research.

Reliability and Validity of an Instrument of COVID-19 Patient-Reported Symptoms in Outpatients

C. Gwaltney, S. Sivapalasingam, A. Podolanczuk, 2022, JAMA network open.

The Annual Meeting of the Society for Research on Nicotine and Tobacco

John J. B. Allen, Thomas R. Kirchner, Sarah M. Scholl, 2009 .

Experiences of demand and control in daily life as correlates of subclinical carotid atherosclerosis in a healthy older sample.

T. Kamarck, S. Shiffman, C. Gwaltney, 2004, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Adolescent first lapse following smoking cessation: situation characteristics, precipitants and proximal influences.

Richard A. Brown, S. Ramsey, D. Strong, 2011, Addictive behaviors.

Contingency management and motivational enhancement: a randomized clinical trial for college student smokers.

C. Kahler, C. Gwaltney, P. Monti, 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Effects of tobacco deprivation on alcohol cue reactivity and drinking among young adults.

C. Gwaltney, D. Abrams, A. Sirota, 2004, Addictive behaviors.

Cognitive and social learning models of drug dependence: implications for the assessment of tobacco dependence in adolescents.

C. Gwaltney, T. Brandon, T. Herzog, 2004, Addiction.

Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective

A. Hamed, J. Paty, C. Gwaltney, 2021, Orphanet Journal of Rare Diseases.

Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.

David Cella, Stephen Joel Coons, Ron D Hays, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Commentary: incorporating patient-reported outcomes in periodontal clinical trials.

C. Gwaltney, M. McGuire, E. T. Scheyer, 2014, Journal of periodontology.

The effect of bupropion on nicotine craving and withdrawal

S. Shiffman, S. Shiffman, J. Paty, 2000, Psychopharmacology.

Immediate antecedents of cigarette smoking: an analysis of unrestricted smoking patterns.

Qianyu Dang, J. Paty, C. Gwaltney, 2004, Journal of abnormal psychology.

Ecological momentary assessment of adolescent smoking cessation: a feasibility study.

C. Kahler, C. Gwaltney, S. Colby, 2008, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study

C. Gwaltney, A. Barzi, D. Melisi, 2021, Oncology and Therapy.

Does heightened affect make smoking cues more salient?

S. Shiffman, C. Gwaltney, 2008, Journal of abnormal psychology.

Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies.

C. Gwaltney, K. Dragnev, K. Skaltsa, 2021, Clinical lung cancer.

Quality of life patient-reported outcomes for locally advanced cutaneous melanoma

C. Gwaltney, Mona L. Martin, J. Zager, 2017, Melanoma research.

Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders.

James MacKillop, Jennifer W Tidey, Robert Miranda, 2010, Journal of abnormal psychology.

Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria

C. Gwaltney, A. Glasmacher, J. Szer, 2022, European journal of haematology.

Hostility, cigarette smoking, and responses to a lab-based social stressor.

T. Kamarck, C. Kahler, C. Gwaltney, 2009, Experimental and clinical psychopharmacology.

Frequency of Spousal Interaction and 3-Year Progression of Carotid Artery Intima Medial Thickness: The Pittsburgh Healthy Heart Project

T. Kamarck, S. Shiffman, C. Gwaltney, 2005, Psychosomatic medicine.

Attentional bias predicts outcome in smoking cessation.

S. Shiffman, M. Sayette, J. Paty, 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Self-efficacy and smoking cessation: a meta-analysis.

Jane Metrik, Saul Shiffman, S. Shiffman, 2009, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

Creating a personalized evaluation framework for patient-reported outcomes: an illustration using the EQ-5D visual analogue scale

A. Shields, C. Gwaltney, M. Reaney, 2018, Expert review of pharmacoeconomics & outcomes research.

Using Individual Experiences With Experimental Medications to Predict Medication-Taking Behavior Postauthorization: A DIA Study Endpoints Workstream

C. McHorney, O. Chassany, C. Gwaltney, 2017, Therapeutic innovation & regulatory science.

Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment.

J. McGeary, C. Gwaltney, J. MacKillop, 2010, Journal of abnormal psychology.

Development and psychometric validation of the Nausea/Vomiting Symptom Assessment patient-reported outcome (PRO) instrument for adults with secondary hyperparathyroidism

C. McHorney, L. Burke, C. Gwaltney, 2018, Journal of Patient-Reported Outcomes.

Hearing the voice of the heart failure patient: key experiences identified in qualitative interviews

C. Gwaltney, Mona L. Martin, R. Ariely, 2012 .

Does smoking abstinence self-efficacy vary across situations? Identifying context-specificity within the Relapse Situation Efficacy Questionnaire.

G. Norman, S. Shiffman, S. Shiffman, 2001, Journal of consulting and clinical psychology.

Content Validity of HIT‐6 as a Measure of Headache Impact in People With Migraine: A Narrative Review

Carrie R. Houts, C. Gwaltney, R. Cady, 2019, Headache.

Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo‐controlled pilot study

C. Gwaltney, P. Monti, J. Tidey, 2017, Addiction biology.

Contingency Management for Adolescent Smokers: An Exploratory Study

C. Kahler, C. Gwaltney, P. Monti, 2007 .

Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure

C. Gwaltney, B. Pieske, Lothar Roessig, 2020, Health and Quality of Life Outcomes.

Overcoming limitations in previous research on exercise as a smoking cessation treatment: rationale and design of the "Quit for Health" trial.

David M Williams, C. Gwaltney, S. Dunsiger, 2014, Contemporary clinical trials.

Measuring and interpreting patient-reported outcome data from clinical trials of diabetes medication

C. Gwaltney, M. Reaney, 2014 .

Motivational interviewing versus feedback only in emergency care for young adult problem drinking.

C. Gwaltney, R. Woolard, P. Monti, 2007, Addiction.

Moderators and mediators of two brief interventions for alcohol in the emergency department.

C. Gwaltney, P. Monti, N. Barnett, 2010, Addiction.

A comparison of Er,Cr:YSGG laser to minimally invasive surgical technique in the treatment of intrabony defects: six-month results of a multicenter, randomized, controlled study.

C. Gwaltney, M. McGuire, J. Gunsolley, 2020, Journal of periodontology.

Patient-reported outcomes (PROs) in dental clinical trials and product development: introduction to scientific and regulatory considerations.

C. Gwaltney, 2010, The journal of evidence-based dental practice.

Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study

C. Gwaltney, A. Barzi, J. Trojan, 2021, Quality of Life Research.

With others or alone? Adolescent individual differences in the context of smoking lapses.

L. C. Bidwell, C. Gwaltney, M. Roberts, 2015, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial.

S. Shiffman, C. Gwaltney, S. G. Ferguson, 2006, Journal of consulting and clinical psychology.

Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy

S. Shiffman, M. Balabanis, C. Gwaltney, 2006, Psychopharmacology.

Dynamic effects of self-efficacy on smoking lapse and relapse.

S Shiffman, S. Shiffman, J. Paty, 2000, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Situational correlates of abstinence self-efficacy.

S. Shiffman, M. Sayette, C. Gwaltney, 2005, Journal of abnormal psychology.

Reduction of abstinence induced withdrawal and craving using nicotine replacement therapy

S. Shiffman, M. Balabanis, C. Gwaltney, 2006 .

Pharmacotherapy for adolescent smoking cessation.

C. Gwaltney, S. Colby, 2007, JAMA.

Studying adolescent smoking in real time: Use of ecological momentary assessment

C. Gwaltney, Jessica A Emerson, 2009 .

Affect, Craving, and Cognition: An EMA Study of ad libitum Adolescent Smoking

C. Gwaltney, A. Waters, R. Dvorak, 2018, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

Implicit associations between smoking and social consequences among smokers in cessation treatment.

Stacey B. Daughters, T. Palfai, C. Kahler, 2007, Behaviour research and therapy.

One Programme, Four Stakeholders: An Overview of the Utilisation of Patient-Reported Outcomes in Intervention Development to Meet the Needs of Regulators, Payers, Healthcare Professionals and Patients

C. Gwaltney, B. Curtis, E. Bush, 2015, Pharmaceutical Medicine.

Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials.

J. Paty, C. Gwaltney, A. Dueck, 2017, Leukemia research.

Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease

Carrie R. Houts, A. Shields, C. Gwaltney, 2022, Journal of patient-reported outcomes.

Development of a Patient-Reported Outcome Questionnaire to Evaluate Primary Mitochondrial Myopathy Symptoms: The Primary Mitochondrial Myopathy Symptom Assessment.

A. Shields, C. Gwaltney, J. Stokes, 2020, Journal of clinical neuromuscular disease.

High Hostility Among Smokers Predicts Slower Recognition of Positive Facial Emotion.

C. Kahler, C. Gwaltney, R. McHugh, 2012, Personality and individual differences.

Using self-efficacy judgments to predict characteristics of lapses to smoking.

S. Shiffman, J. Paty, C. Gwaltney, 2002, Journal of consulting and clinical psychology.

Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study.

J. McGeary, C. Gwaltney, L. Ray, 2008, Alcoholism, clinical and experimental research.

Measurement Equivalence of Patient-Reported Outcome Measures Migrated to Electronic Formats: A Review of Evidence and Recommendations for Clinical Trials and Bring Your Own Device

Willie Muehlhausen, Bill Byrom, Chad Gwaltney, 2019, Therapeutic innovation & regulatory science.

Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial

C. Gwaltney, L. Ray, P. Monti, 2014, Addiction biology.

Characterizing subjective responses to alcohol among adolescent problem drinkers.

Elizabeth K. Reynolds, C. Gwaltney, L. Ray, 2014, Journal of abnormal psychology.

Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.

S. Shiffman, J. McGeary, J. Paty, 2007, Alcoholism, clinical and experimental research.

The Psoriasis Symptom Diary: development and content validity of a novel patient‐reported outcome instrument

B. Strober, M. Lebwohl, C. Gwaltney, 2014, International journal of dermatology.

Item-level psychometric properties for a new patient-reported psoriasis symptom diary.

B. Strober, A. Gottlieb, B. Elewski, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers.

John McGeary, Chad Gwaltney, James MacKillop, 2009, Experimental and clinical psychopharmacology.

Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving.

S Shiffman, S. Shiffman, J. Paty, 2000, Addiction.

Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy

S. Shiffman, C. Gwaltney, S. G. Ferguson, 2006, Psychopharmacology.

Analyzing Milestones in Smoking Cessation

S. Shiffman, C. Gwaltney, Deborah Scharf, 2006 .

Affective and Situational Precipitants of Smoking Lapses among Adolescents.

Jennifer E. Merrill, C. Kahler, C. Gwaltney, 2019, Nicotine & Tobacco Research.

Relationship between momentary affect states and self-efficacy in adolescent smokers.

C. Kahler, C. Gwaltney, B. Hoeppner, 2014, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Application of ecological momentary assessment to the study of marital adjustment and social interactions during daily life.

T. Kamarck, S. Shiffman, C. Gwaltney, 2006, Journal of family psychology : JFP : journal of the Division of Family Psychology of the American Psychological Association.

Mobility assessment using wearable technology in patients with late-onset Pompe disease

A. Hamed, P. DasMahapatra, C. Gwaltney, 2019, npj Digital Medicine.

Living with heart failure: patient experiences and implications for physical activity and daily living

C. Gwaltney, Jersey Chen, A. Niklasson, 2022, ESC heart failure.

Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease

A. Hamed, P. DasMahapatra, C. Gwaltney, 2021, Molecular Genetics and Metabolism Reports.

Development and content validity of the Barth Syndrome Symptom Assessment (BTHS-SA) for adolescents and adults

A. Shields, C. Gwaltney, J. Stokes, 2021, Orphanet Journal of Rare Diseases.

Self-Paced Exercise, Affective Response, and Exercise Adherence: A Preliminary Investigation Using Ecological Momentary Assessment.

David M Williams, C. Gwaltney, S. Dunsiger, 2016, Journal of Sport & Exercise Psychology (JSEP).

Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials

Sanjiv J. Shah, M. Senni, C. Gwaltney, 2020, Digital Biomarkers.

Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study

P. DasMahapatra, C. Gwaltney, C. Ivanescu, 2023, Neurology. Clinical practice.

Relationship between momentary affect states and self-efficacy in adolescent smokers.

C. Kahler, C. Gwaltney, B. Hoeppner, 2014, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Recommending Self-Paced Exercise among Overweight and Obese Adults: a Randomized Pilot Study

David M Williams, C. Gwaltney, S. Dunsiger, 2015, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

“Bring Your Own Device” (BYOD): The Future of Field-Based Patient-Reported Outcome Data Collection in Clinical Trials?

C. Gwaltney, S. Coons, P. O’Donohoe, 2015, Therapeutic innovation & regulatory science.